Learn more

NAT INST IMMUNOLOGY

Overview
  • Total Patents
    118
  • GoodIP Patent Rank
    202,557
  • Filing trend
    ⇩ 100.0%
About

NAT INST IMMUNOLOGY has a total of 118 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 1985. It filed its patents most often in United States, EPO (European Patent Office) and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals, biotechnology and environmental technology are SMITHKLINE BEECHAM BIOLOGICALS SA, THE GOVERNMENT OF THE US SECRETARY DEPT OF HEALTH AND HUMAN SERVICES and CT INGENIERIA GENETICA BIOTECH.

Patent filings per year

Chart showing NAT INST IMMUNOLOGYs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Surolia Avadhesha 19
#2 Panda Amulya Kumar 13
#3 Mukherjee Rama 10
#4 Surolia Namita 9
#5 Jaggi Manu 9
#6 Gupta Sarika 9
#7 Suri Anil Kumar 7
#8 Kumar Gyanendra 7
#9 Parasuraman Prasanna 7
#10 Vrati Sudhanshu 6

Latest patents

Publication Filing date Title
WO2014184797A2 Hemoglobin receptor as novel vaccine for leishmaniasis
US2014377228A1 Bone Marrow-Derived Cells Ameliorates The Pathological Consequences Of The Liver In Case Of Alpha1-Antitrypsin Deficiency
US2014351966A1 Shortcut procedure of transgene integration by hypotonic shock into male germinal cells for gene expression and transgenesis
WO2013065009A1 A sortase-click reaction suite for synthesis of multivalent dendrimeric protein assembly
WO2012164480A1 A vaccine composition capable of inducing memory antibody response from single point immunization
WO2012156811A2 Compositions useful for the treatment of inflammatory disease or disorders
WO2012150495A1 Synthetic peptides and random copolymers for the treatment of autoimmune disorders
WO2012140677A2 ISOLATION, CLONING, SEQUENCING AND FUNCTIONAL ANALYSIS OF β-CASEIN PROMOTER ALONG WITH THE REGIONS OF EXON1, INTRON1 AND EXON2 USING MAMMARY GLAND DERIVED CELL LINE OF BUFFALO (BUBULUS BUBALIS)
WO2012038801A1 A spray dried powder formulation for vaccines entrapping alum and the antigen in biodegradable polymer particles
EP2591108A1 A RECOMBINANT VACCINE AGAINST CLOSTRIDIUM PERFRINGENS INFECTION AND EPSILON (e ) TOXIN INTOXICATION
WO2011083493A1 Human chorionic gonadotropin (hcg) based vaccine for prevention and treatment of cancer
EP2398922A2 Recql4/recql4 variant-p53 complex for altered mitochondrial function in rothmund-thomson syndrome
US2011150843A1 Method for the therapeutic correction of hemophilia a by transplanting bone marrow cells
BRPI1004126A2 Process for Detecting Leishmaniasis Using Antigenic Prohibitin Peptide
US2010190832A1 Mechanism-based inhibitors of transthyretin amyloidosis: studies with biphenyl ethers and structural templates
US2011178142A1 Pharmaceutical composition for therapeutic or prophylactic treatment of bacterial infections and associated diseases
EP2100970A2 Ig genes specific oligonucleotides and uses thereof
CN101873869A Biodegradable polymer support and preparation method thereof
CN102088997A Compositions useful for the treatment of diabetes and other chronic disorder
EP2147093A1 Process for obtaining bioactive recombinant protein from inclusion bodies